Two researchers at PNNL have been named fellows of the American Chemical Society: Karthikeyan Ramasamy and Yuyan Shao.

Algae can collect and concentrate rare earth metals from seawater—an alternative to imported sources mined from the ground.

PNNL’s wide-ranging report maps the current nanobiotechnology landscape, flags potential concerns, and details the need for an organizing body to coordinate currently disparate disciplines.

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

Lauren Charles, a chief data scientist at PNNL, joined the editorial board of the largest open access journal published by Nature Research.

Joshua Adkins and Jamie Lo will lead PMedIC, Pacific Northwest National Laboratory and Oregon Health & Science University’s joint research institute.

PNNL receives a 2023 Federal Laboratory Consortium Far West Regional Award for a technological innovation that could help make the U.S. a producer of critical minerals used in electronics and energy production.

By mimicking nature, scientists make a breakthrough in breaking down wood.

COVID-19 infections at PNNL early in the pandemic were caused by a wide variety of viral sequences, according to a new analysis by Laboratory researchers.

SAGE is a high-efficiency genome integration strategy for bacteria that makes the stable introduction of new traits simple for newly discovered microbes.

PNNL-developed catalytic process and catalyst to upgrade ethanol to sustainable aviation fuel wins American Chemical Society award.

A PNNL innovation uses steam to recover heat from the high-temperature reactor effluent in the HTL process, substantially reducing the propensity for fouling and potentially reducing costs.

PNNL researchers discovered a faster, more economical method to verify the amount of biofuel in mixtures of bio and fossil fuel.

Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.

Exploring why some brains are more resilient to the impact of Alzheimer’s disease could lead to improved diagnoses, treatment and prevention.

Advanced proteomic analysis tools dig deep into human blood plasma to understand the molecular nature of advanced alcoholic disease.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

A paper by PNNL researchers has been chosen as one of 32 NIEHS Papers of the Year—a top 1% honor in the research field.

Radha Kishan Motkuri lends skill and knowledge to co-lead special edition journal.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.